LNTH
Lantheus Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$100.55
−0.25%Forward multiples
Based on analyst estimates
- P/E forward
- 17.85x
- P/E 2026E
- 18.60x
- P/E 2027E
- 15.72x
- P/E 2028E
- 12.80x
- P/S forward
- 4.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.88x
- PEG TTM
- 0.71x
- Price / book
- 5.01x
- Price / sales
- 4.22x
- Price / cash flow
- 12.21x
Enterprise value
- Enterprise value
- $6.6B
- EV / sales
- 4.24x
- EV / EBITDA
- 14.18x
- EV / EBIT
- 21.82x
- Market cap
- $6.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026